Triasima Portfolio Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,213
| Closed | -$3.01M | – | 167 |
|
|
2025
Q1 | $3.01M | Sell |
6,213
-5,447
| -47% | -$2.64M | 0.59% | 58 |
|
|
2024
Q4 | $4.7M | Buy |
11,660
+127
| +1% | +$51.1K | 0.91% | 32 |
|
|
2024
Q3 | $5.36M | Buy |
11,533
+28
| +0.2% | +$13K | 1.21% | 26 |
|
|
2024
Q2 | $5.39M | Buy |
11,505
+3
| +0% | +$1.41K | 0.49% | 41 |
|
|
2024
Q1 | $4.81M | Sell |
11,502
-1,303
| -10% | -$545K | 0.4% | 48 |
|
|
2023
Q4 | $5.21M | Sell |
12,805
-2,227
| -15% | -$906K | 0.43% | 45 |
|
|
2023
Q3 | $5.23M | Buy |
15,032
+1,101
| +8% | +$383K | 0.48% | 43 |
|
|
2023
Q2 | $6.49M | Buy |
13,931
+2,715
| +24% | +$1.26M | 0.41% | 46 |
|
|
2023
Q1 | $3.53M | Sell |
11,216
-8,773
| -44% | -$2.76M | 0.29% | 57 |
|
|
2022
Q4 | $5.77M | Buy |
19,989
+1,389
| +7% | +$401K | 0.44% | 40 |
|
|
2022
Q3 | $5.39M | Buy |
18,600
+9,610
| +107% | +$2.78M | 0.44% | 41 |
|
|
2022
Q2 | $2.53M | Buy |
+8,990
| New | +$2.53M | 0.18% | 68 |
|